Current Landscape and Future Direction of PD-1/PD-L1 Checkpoint Inhibitors in Cancer Treatment

被引：2
|
作者：
Serrati, Simona [1 ]
Margheri, Francesca [2 ]
机构：
[1] IRCCS Ist Tumori Giovanni Paolo II, Lab Expt Pharmacol, I-70124 Bari, Italy
[2] Univ Florence, Dept Expt & Clin Biomed Sci, I-50134 Florence, Italy
来源：
BIOMOLECULES | 2023年 / 13卷 / 08期
关键词：
IMMUNE; RESISTANCE;
D O I：
10.3390/biom13081209
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Pyrazolones as inhibitors of immune checkpoint blocking the PD-1/PD-L1 interaction
    Le Biannic, Raphael
    Magnez, Romain
    Klupsch, Frederique
    Leleu-Chavain, Natascha
    Thiroux, Bryan
    Tardy, Morgane
    El Bouazzati, Hassiba
    Dezitter, Xavier
    Renault, Nicolas
    Vergoten, Gerard
    Bailly, Christian
    Quesnel, Bruno
    Thuru, Xavier
    Millet, Regis
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 236
  • [32] PD-1/PD-L1 inhibitors in multiple myeloma: The present and the future
    Jelinek, T.
    Hajek, R.
    ONCOIMMUNOLOGY, 2016, 5 (12):
  • [33] PD-1/PD-L1 checkpoint in hematological malignancies
    Annibali, O.
    Crescenzi, A.
    Tomarchio, V.
    Pagano, A.
    Bianchi, A.
    Grifoni, A.
    Avvisati, G.
    LEUKEMIA RESEARCH, 2018, 67 : 45 - 55
  • [34] PD-1/PD-L1 pathway: current researches in cancer
    Han, Yanyan
    Liu, Dandan
    Li, Lianhong
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (03): : 727 - 742
  • [35] Effectiveness of PD-1/PD-L1 inhibitors in the treatment of lung cancer: Brightness and challenge
    Ying Yang
    Yongfeng Yu
    Shun Lu
    Science China Life Sciences, 2020, 63 : 1499 - 1514
  • [36] Adipose PD-L1 Modulates PD-1/PD-L1 Checkpoint Blockade Immunotherapy Efficacy in Breast Cancer
    Wu, Bogang
    Sun, Xiujie
    Gupta, Harshita B.
    Yuan, Bin
    Li, Jingwei
    Ge, Fei
    Chiang, Huai-Chin
    Zhang, Xiaowen
    Zhang, Chi
    Zhang, Deyi
    Yang, Jing
    Hu, Yanfen
    Curiel, Tyler J.
    Li, Rong
    ONCOIMMUNOLOGY, 2018, 7 (11):
  • [37] Effectiveness of PD-1/PD-L1 inhibitors in the treatment of lung cancer: Brightness and challenge
    Ying Yang
    Yongfeng Yu
    Shun Lu
    Science China(Life Sciences), 2020, 63 (10) : 1499 - 1514
  • [38] Immunotherapies based on PD-1/PD-L1 pathway inhibitors in ovarian cancer treatment
    Pawlowska, A.
    Suszczyk, D.
    Okla, K.
    Barczynski, B.
    Kotarski, J.
    Wertel, I.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2019, 195 (03): : 334 - 344
  • [39] Effectiveness of PD-1/PD-L1 inhibitors in the treatment of lung cancer: Brightness and challenge
    Ying Yang
    Yongfeng Yu
    Shun Lu
    Science China(Life Sciences) , 2020, (10) : 1499 - 1514
  • [40] Effectiveness of PD-1/PD-L1 inhibitors in the treatment of lung cancer: Brightness and challenge
    Yang, Ying
    Yu, Yongfeng
    Lu, Shun
    SCIENCE CHINA-LIFE SCIENCES, 2020, 63 (10) : 1499 - 1514
12345